Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 May, 2018 15:33 IST
IRB Infra achieves financial closure for NHAI road project
Source: IRIS | 14 Feb, 2018, 10.13AM
Comments  |  Post Comment

IRB Infrastructure Developers announced that its wholly owned subsidiary Kishangarh Gulabpura Tollway has achieved financial closure in terms of the concession agreement executed with NHAI, by tying up of the project finance of Rs 10.20 billion.

The total cost of the project is Rs 15.26 billion, out of which equity contribution / internal accrual by the company will be Rs 5.06 billion and remaining will be funded through project finance of Rs 10.20 billion.

The project involves Six Laning of Kishangarh to Gulabpura Section of NH 79A and NH 79 in the state of Rajasthan (length 90.000 km) on DBFOT (Toll) mode, under NHDP Phase-Y Package-l (the Project). The concession period of the Project is 20 years including construction period of 910 days.

Shares of the company declined Rs 0.45, or 0.2%, to trade at Rs 226.80. The total volume of shares traded was 45,846 at the BSE (10.00 a.m., Wednesday).





IRB Infrastructure Developers Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Ashok Leyland quarterly net surges 40% - 18-May-2018 16:38
Bank of Baroda enters into MoU with CCRL - 18-May-2018 16:31
Strides Shasun turns to loss in Jan-Mar quarter - 18-May-2018 15:32
Bajaj Auto quarterly net up 36.33% - 18-May-2018 15:24
3i Infotech Services forays into retail as new vertical - 18-May-2018 13:04
Shriram Transport Finance inks MoU with HPCL - 18-May-2018 12:49
Airtel, Amazon India join hands to introduce a range of affordable 4G smartphones - 18-May-2018 12:11
L&T Construction wins orders worth Rs 15.04 bn - 18-May-2018 10:12
Glenmark Pharmaceuticals updates on clinical study of GBR 830 - 18-May-2018 10:08
R-Jio, Screenz partner to provide entertainment-based interactive platform - 18-May-2018 10:03
Sun Pharma launches generic Welchol tablets in US - 18-May-2018 09:49
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer